Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-30
DOI
10.1038/srep38034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats
- (2015) Bahaa Al-Trad et al. Diabetology & Metabolic Syndrome
- Biotin amelioration of nephrotoxicity in streptozotocin-induced diabetic mice
- (2015) Badr A. Aldahmash et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
- (2015) Ivonne Loeffler et al. Cells
- Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism
- (2014) Suxian Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats
- (2014) Sabbir Khan et al. FOOD AND CHEMICAL TOXICOLOGY
- Insulin Regulates Nitric Oxide Production in the Kidney Collecting Duct Cells
- (2014) Gaurav Pandey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression
- (2014) X. M. Yao et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy
- (2014) Xiaojie Wang et al. KIDNEY INTERNATIONAL
- IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
- (2014) Frency Varghese et al. PLoS One
- Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
- (2014) Kei Fukami et al. Diabetology & Metabolic Syndrome
- Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome
- (2014) Kyoko Ohbu-Murayama et al. Journal of Diabetes Investigation
- Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
- (2014) Akiko Takazakura et al. Journal of Diabetes Investigation
- Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study
- (2014) Sune F Nielsen et al. Lancet Diabetes & Endocrinology
- Digital image analysis approach for lipid droplet size quantitation of Oil Red O-stained cultured cells
- (2013) Manuel J. Deutsch et al. ANALYTICAL BIOCHEMISTRY
- Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
- (2013) Marios Margaritis et al. ANTIOXIDANTS & REDOX SIGNALING
- Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease
- (2013) Toshihiko Ishimitsu et al. Clinical and Experimental Nephrology
- Antihypertensive Effects of Statins: A Meta-Analysis of Prospective Controlled Studies
- (2013) Alexandros Briasoulis et al. Journal of Clinical Hypertension
- Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
- (2013) Derrick M. Van Rooyen et al. JOURNAL OF HEPATOLOGY
- Deletion of the Insulin Receptor in the Proximal Tubule Promotes Hyperglycemia
- (2013) S. Tiwari et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Expression of HIV transgene aggravates kidney injury in diabetic mice
- (2013) Sandeep K. Mallipattu et al. KIDNEY INTERNATIONAL
- Wilm's Tumor-1 Protein Levels in Urinary Exosomes from Diabetic Patients with or without Proteinuria
- (2013) Anuradha Kalani et al. PLoS One
- Ezetimibe Ameliorates Early Diabetic Nephropathy in db/db Mice
- (2012) Yukinori Tamura et al. Journal of Atherosclerosis and Thrombosis
- Stimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism
- (2012) Maria Vogelauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fluvastatin inhibits high glucose–induced nuclear factor kappa B activation in renal tubular epithelial cells
- (2012) Ping Gao et al. JOURNAL OF NEPHROLOGY
- Statins for people at low risk of cardiovascular disease – Authors' reply
- (2012) Borislava Mihaylova et al. LANCET
- HDAC inhibitors in kidney development and disease
- (2012) Lauren L. Brilli et al. PEDIATRIC NEPHROLOGY
- Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
- (2012) Jeong Kim et al. ARTHRITIS RESEARCH & THERAPY
- Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism
- (2011) Andrew Advani et al. AMERICAN JOURNAL OF PATHOLOGY
- Atorvastatin Has no Effects on Kidney Tissues of Wistar Albino Rats in the Long-Term Intake: An Electron Microscopic Study
- (2011) Ayfer Aktas et al. INTERNATIONAL JOURNAL OF MORPHOLOGY
- Atorvastatin 10mg plus ezetimibe 10mg compared with atorvastatin 20mg: Impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease
- (2011) Yusuke Uemura et al. Journal of Cardiology
- Valproic Acid Attenuates Proteinuria and Kidney Injury
- (2011) K. Van Beneden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats
- (2011) Lin Lu et al. Journal of Zhejiang University-SCIENCE B
- Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor
- (2011) Richard E. Gilbert et al. KIDNEY INTERNATIONAL
- Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
- (2011) Sungjin Chung et al. Diabetes & Metabolism Journal
- E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation
- (2010) Il Je Cho et al. HEPATOLOGY
- Morphometric and Visual Evaluation of Fibrosis in Renal Biopsies
- (2010) A. B. Farris et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
- (2009) Philippe Dje N'Guessan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical Insights From the Treating to New Targets Trial
- (2009) David D. Waters PROGRESS IN CARDIOVASCULAR DISEASES
- Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2
- (2008) Y.-C. Lin et al. CANCER RESEARCH
- The Role of Inflammatory Cytokines in Diabetic Nephropathy
- (2008) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Analysis of epigenetic modifications of chromatin at specific gene loci by native chromatin immunoprecipitation of nucleosomes isolated using hydroxyapatite chromatography
- (2008) Marjorie Brand et al. Nature Protocols
- Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor
- (2008) S. Tiwari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
- (2008) Chao-Yung Wang et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started